Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Recurrent or Progressive PFA Ependymoma
NCT07226453Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- May 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in ependymoma, sponsored by University of California, San Francisco. Started May 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT07226453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226453.